Literature DB >> 29105022

Homozygous Dkk1 Knockout Mice Exhibit High Bone Mass Phenotype Due to Increased Bone Formation.

Michelle M McDonald1,2, Alyson Morse1,3, Aaron Schindeler1,3, Kathy Mikulec1, Lauren Peacock1, Tegan Cheng1,3, Justin Bobyn1,3, Lucinda Lee1,3, Paul A Baldock2, Peter I Croucher2, Patrick P L Tam4,5, David G Little6,7.   

Abstract

Wnt antagonist Dkk1 is a negative regulator of bone formation and Dkk1 +/- heterozygous mice display a high bone mass phenotype. Complete loss of Dkk1 function disrupts embryonic head development. Homozygous Dkk1 -/- mice that were heterozygous for Wnt3 loss of function mutation (termed Dkk1 KO) are viable and allowed studying the effects of homozygous inactivation of Dkk1 on bone formation. Dkk1 KO mice showed a high bone mass phenotype exceeding that of heterozygous mice as well as a high incidence of polydactyly and kinky tails. Whole body bone density was increased in the Dkk1 KO mice as shown by longitudinal dual-energy X-ray absorptiometry. MicroCT analysis of the distal femur revealed up to 3-fold increases in trabecular bone volume and up to 2-fold increases in the vertebrae, compared to wild type controls. Cortical bone was increased in both the tibiae and vertebrae, which correlated with increased strength in tibial 4-point bending and vertebral compression tests. Dynamic histomorphometry identified increased bone formation as the mechanism underlying the high bone mass phenotype in Dkk1 KO mice, with no changes in bone resorption. Mice featuring only Wnt3 heterozygosity showed no evident bone phenotype. Our findings highlight a critical role for Dkk1 in the regulation of bone formation and a gene dose-dependent response to loss of DKK1 function. Targeting Dkk1 to enhance bone formation offers therapeutic potential for osteoporosis.

Entities:  

Keywords:  Bone; Dkk1; High bone mass; Knockout model; Wnt-signalling

Mesh:

Substances:

Year:  2017        PMID: 29105022     DOI: 10.1007/s00223-017-0338-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  4 in total

Review 1.  Wnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis.

Authors:  Daniela Cici; Addolorata Corrado; Cinzia Rotondo; Francesco P Cantatore
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

2.  Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.

Authors:  Nick Hildebrandt; Juliane Colditz; Lorenz C Hofbauer; Martina Rauner; Caio Dutra; Paula Goes; Juliane Salbach-Hirsch; Sylvia Thiele
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

3.  Anti-DKK1 Enhances the Early Osteogenic Differentiation of Human Adipose-Derived Stem/Stromal Cells.

Authors:  Yiyun Wang; Stefano Negri; Zhao Li; Jiajia Xu; Ching-Yun Hsu; Bruno Peault; Kristen Broderick; Aaron W James
Journal:  Stem Cells Dev       Date:  2020-06-22       Impact factor: 3.272

Review 4.  Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis.

Authors:  Núria Martínez-Gil; Nerea Ugartondo; Daniel Grinberg; Susanna Balcells
Journal:  Genes (Basel)       Date:  2022-01-13       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.